公司资料
Bio-Techne 股价、新闻与催化剂
- 股票代码:
- TECH
- 交易所:
- NASDAQ
- 行业:
- Life Science Tools
- 所在地:
- United States
股票表现
72.39 USD (-0.01%)
收盘价
最后更新: 2026年8月17日
7.79B USD
市值
股价为何变动
As of Aug 17, 2026, TECH was little changed and closed at $72.39. No new same-company headline was identified in the current news window.
公司概览
Life-Science Research Tools
Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing. Its portfolio serves academic laboratories, biopharmaceutical companies, and diagnostic customers worldwide.
R&D Systems
R&D Systems supports discovery, translational research, and bioprocessing with proteins, antibodies, assays, and related reagents. The portfolio includes GMP-grade proteins used in cell and gene therapy development and manufacturing.
Bio-Techne Spatial
The Spatial business provides technologies for analyzing the location and expression of biological targets within tissue. These tools connect molecular signals with tissue architecture in oncology and translational medicine.
Bio-Techne Diagnostics
The Diagnostics portfolio includes immunoassays, blood-chemistry and blood-gas quality controls, hematology controls, and custom reagents for diagnostic manufacturers and clinical laboratories.
Pending Acquisition
Bio-Techne has agreed to be acquired by Merck KGaA, Darmstadt, Germany. Until the transaction closes, it continues operating through its three customer-focused brands and global research and diagnostic infrastructure.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。